These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 20484035)
1. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation. Yamashita T; Honda M; Nio K; Nakamoto Y; Yamashita T; Takamura H; Tani T; Zen Y; Kaneko S Cancer Res; 2010 Jun; 70(11):4687-97. PubMed ID: 20484035 [TBL] [Abstract][Full Text] [Related]
2. EpCAM-targeted therapy for human hepatocellular carcinoma. Ogawa K; Tanaka S; Matsumura S; Murakata A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Tanabe M; Arii S Ann Surg Oncol; 2014 Apr; 21(4):1314-22. PubMed ID: 24370904 [TBL] [Abstract][Full Text] [Related]
3. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. Terris B; Cavard C; Perret C J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402 [TBL] [Abstract][Full Text] [Related]
4. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma. Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811 [TBL] [Abstract][Full Text] [Related]
5. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway. Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993 [TBL] [Abstract][Full Text] [Related]
6. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609 [TBL] [Abstract][Full Text] [Related]
7. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Yamashita T; Honda M; Nakamoto Y; Baba M; Nio K; Hara Y; Zeng SS; Hayashi T; Kondo M; Takatori H; Yamashita T; Mizukoshi E; Ikeda H; Zen Y; Takamura H; Wang XW; Kaneko S Hepatology; 2013 Apr; 57(4):1484-97. PubMed ID: 23174907 [TBL] [Abstract][Full Text] [Related]
8. Beta-Hydroxyisovaleryl-Shikonin Eradicates Epithelial Cell Adhesion Molecule-Positive Liver Cancer Stem Cells by Suppressing dUTP Pyrophosphatase Expression. Asahina Y; Takatori H; Nio K; Okada H; Hayashi T; Hayashi T; Hashiba T; Suda T; Nishitani M; Sugimoto S; Honda M; Kaneko S; Yamashita T Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003473 [TBL] [Abstract][Full Text] [Related]
9. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E Cells; 2020 May; 9(5):. PubMed ID: 32408542 [TBL] [Abstract][Full Text] [Related]
10. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Yamashita T; Budhu A; Forgues M; Wang XW Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828 [TBL] [Abstract][Full Text] [Related]
11. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Yamashita T; Ji J; Budhu A; Forgues M; Yang W; Wang HY; Jia H; Ye Q; Qin LX; Wauthier E; Reid LM; Minato H; Honda M; Kaneko S; Tang ZY; Wang XW Gastroenterology; 2009 Mar; 136(3):1012-24. PubMed ID: 19150350 [TBL] [Abstract][Full Text] [Related]
12. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863 [TBL] [Abstract][Full Text] [Related]